Healthcare is shifting from treating disease after it appears to preventing, restoring, and optimizing health throughout the lifespan. Breakthroughs in regenerative medicine, immune biology, metabolic science, and personalized therapeutics are transforming how patients are diagnosed, treated, and supported over time.
 

Gore Range Capital invests in companies building next-generation healthcare platforms designed to address the root causes of aging, chronic disease, and functional decline. We focus on innovations that combine scientific discovery with real-world clinical and commercial scalability.
 

One of the most powerful entry points into these biological systems is the skin. As the body’s largest and most visible organ, skin reflects key biological processes including inflammation, immune health, microbiome balance, and regenerative repair. Because skin is clinically accessible and biologically informative, it provides a unique window into broader health conditions and aging pathways.
 

By investing in technologies and therapies that begin with clinically accessible biological systems and expand into broader healthcare applications, Gore Range seeks to support innovations that improve quality of life, extend healthspan, and build durable, scalable healthcare platforms.